XP-524（Cat No.:I038436）is a selective small molecule inhibitor that targets the protein SCD1 (stearoyl-CoA desaturase 1), an enzyme involved in the biosynthesis of monounsaturated fatty acids. By inhibiting SCD1, XP-524 disrupts lipid metabolism, which plays a key role in cellular processes such as membrane fluidity, signaling, and energy storage. This compound has shown promise in preclinical models as a potential therapeutic for metabolic disorders, including obesity and diabetes, as well as certain cancers. XP-524’s ability to modulate lipid metabolism may provide a novel approach for treating diseases linked to altered lipid homeostasis.